141 related articles for article (PubMed ID: 15059880)
21. Targeting the 90 kDa heat shock protein improves photodynamic therapy.
Ferrario A; Gomer CJ
Cancer Lett; 2010 Mar; 289(2):188-94. PubMed ID: 19733005
[TBL] [Abstract][Full Text] [Related]
22. Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.
Littlepage LE; Sternlicht MD; Rougier N; Phillips J; Gallo E; Yu Y; Williams K; Brenot A; Gordon JI; Werb Z
Cancer Res; 2010 Mar; 70(6):2224-34. PubMed ID: 20215503
[TBL] [Abstract][Full Text] [Related]
23. Ventilator-induced lung injury upregulates and activates gelatinases and EMMPRIN: attenuation by the synthetic matrix metalloproteinase inhibitor, Prinomastat (AG3340).
Foda HD; Rollo EE; Drews M; Conner C; Appelt K; Shalinsky DR; Zucker S
Am J Respir Cell Mol Biol; 2001 Dec; 25(6):717-24. PubMed ID: 11726397
[TBL] [Abstract][Full Text] [Related]
24. Generation of effective antitumor vaccines using photodynamic therapy.
Gollnick SO; Vaughan L; Henderson BW
Cancer Res; 2002 Mar; 62(6):1604-8. PubMed ID: 11912128
[TBL] [Abstract][Full Text] [Related]
25. Molecular determinants of photodynamic therapy for lung cancers.
Usuda J; Ichinose S; Ishizumi T; Ohtani K; Inoue T; Maehara S; Imai K; Shima K; Ohira T; Kato H; Ikeda N
Lasers Surg Med; 2011 Sep; 43(7):591-9. PubMed ID: 22057486
[TBL] [Abstract][Full Text] [Related]
26. Hyperoxygenation enhances the tumor cell killing of photofrin-mediated photodynamic therapy.
Huang Z; Chen Q; Shakil A; Chen H; Beckers J; Shapiro H; Hetzel FW
Photochem Photobiol; 2003 Nov; 78(5):496-502. PubMed ID: 14653582
[TBL] [Abstract][Full Text] [Related]
27. Organ heterogeneity of host-derived matrix metalloproteinase expression and its involvement in multiple-organ metastasis by lung cancer cell lines.
Shiraga M; Yano S; Yamamoto A; Ogawa H; Goto H; Miki T; Miki K; Zhang H; Sone S
Cancer Res; 2002 Oct; 62(20):5967-73. PubMed ID: 12384564
[TBL] [Abstract][Full Text] [Related]
28. ATX-S10(Na)-PDT shows more potent effect on collagen metabolism of human normal and scleroderma dermal fibroblasts than ALA-PDT.
Takahashi H; Komatsu S; Ibe M; Ishida-Yamamoto A; Nakajima S; Sakata I; Iizuka H
Arch Dermatol Res; 2006 Nov; 298(6):257-63. PubMed ID: 16977444
[TBL] [Abstract][Full Text] [Related]
29. Keratinocyte-derived cytokines after photodynamic therapy and their paracrine induction of matrix metalloproteinases in fibroblasts.
Karrer S; Bosserhoff AK; Weiderer P; Landthaler M; Szeimies RM
Br J Dermatol; 2004 Oct; 151(4):776-83. PubMed ID: 15491416
[TBL] [Abstract][Full Text] [Related]
30. High-resolution PET imaging for in vivo monitoring of tumor response after photodynamic therapy in mice.
Lapointe D; Brasseur N; Cadorette J; La Madeleine C; Rodrigue S; van Lier JE; Lecomte R
J Nucl Med; 1999 May; 40(5):876-82. PubMed ID: 10319764
[TBL] [Abstract][Full Text] [Related]
31. IL-6 potentiates tumor resistance to photodynamic therapy (PDT).
Brackett CM; Owczarczak B; Ramsey K; Maier PG; Gollnick SO
Lasers Surg Med; 2011 Sep; 43(7):676-85. PubMed ID: 22057495
[TBL] [Abstract][Full Text] [Related]
32. Angiogenesis induced by photodynamic therapy in normal rat brains.
Jiang F; Zhang ZG; Katakowski M; Robin AM; Faber M; Zhang F; Chopp M
Photochem Photobiol; 2004 Jun; 79(6):494-8. PubMed ID: 15291298
[TBL] [Abstract][Full Text] [Related]
33. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
Chan WS; Brasseur N; La Madeleine C; van Lier JE
Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
[TBL] [Abstract][Full Text] [Related]
34. Histone acetyltransferase p300 is induced by p38MAPK after photodynamic therapy: the therapeutic response is increased by the p300HAT inhibitor anacardic acid.
Tsai YJ; Tsai T; Peng PC; Li PT; Chen CT
Free Radic Biol Med; 2015 Sep; 86():118-32. PubMed ID: 26001729
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo efficacy of photofrin and pheophorbide a, a bacteriochlorin, in photodynamic therapy of colonic cancer cells.
Hajri A; Wack S; Meyer C; Smith MK; Leberquier C; Kedinger M; Aprahamian M
Photochem Photobiol; 2002 Feb; 75(2):140-8. PubMed ID: 11883602
[TBL] [Abstract][Full Text] [Related]
36. Matrix metalloproteinases and their inhibitors regulate in vitro ureteric bud branching morphogenesis.
Pohl M; Sakurai H; Bush KT; Nigam SK
Am J Physiol Renal Physiol; 2000 Nov; 279(5):F891-900. PubMed ID: 11053050
[TBL] [Abstract][Full Text] [Related]
37. Interaction between photodynamic therapy and BCG immunotherapy responsible for the reduced recurrence of treated mouse tumors.
Korbelik M; Sun J; Posakony JJ
Photochem Photobiol; 2001 Apr; 73(4):403-9. PubMed ID: 11332036
[TBL] [Abstract][Full Text] [Related]
38. Sustained activation of the extracellular signal-regulated kinase pathway protects cells from photofrin-mediated photodynamic therapy.
Tong Z; Singh G; Rainbow AJ
Cancer Res; 2002 Oct; 62(19):5528-35. PubMed ID: 12359764
[TBL] [Abstract][Full Text] [Related]
39. 9-Hydroxypheophorbide α-mediated photodynamic therapy induces matrix metalloproteinase-2 (MMP-2) and MMP-9 down-regulation in Hep-2 cells via ROS-mediated suppression of the ERK pathway.
Zhang H; Shen B; Swinarska JT; Li W; Xiao K; He P
Photodiagnosis Photodyn Ther; 2014 Mar; 11(1):55-62. PubMed ID: 24448387
[TBL] [Abstract][Full Text] [Related]
40. Targeting the tumor microenvironment using photodynamic therapy combined with inhibitors of cyclooxygenase-2 or vascular endothelial growth factor.
Ferrario A; Gomer CJ
Methods Mol Biol; 2010; 635():121-32. PubMed ID: 20552344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
